Co-founder, chair of the Board, CEO and holder of an executive
leadership role overseeing all research and non-research functions,
Rallybio LLC.
Senior advisor to New Leaf Venture Partners,
LLC.
Member of the board and chair of the Science and
Technology Committee of Charles River Laboratories International,
Inc.
President of Global Research and Development at AstraZeneca
plc., 2010-2013.
President and senior vice president within
Research and Development, and other roles, Pfizer, Inc.,
1995-2010.
Visiting professor at the Department of Pharmacy
at King’s College, London, 1998-2006 and at the Department of
Biomedical Sciences at the University of Lincoln, 1998-2014.
Considered independent under the Danish Recommendations on
Corporate Governance.
Member of the Board of Directors
since March 2018. Most recently elected in 2022 for a term of one
year.
Chair of the Research & Development Committee since
March 2018.
Member of the Remuneration Committee since
March 2021.
Global corporate leadership
Healthcare and pharma
industry
Medicine & science
Technology
Business development, M&A and external innovation
sourcing
Human capital management
1984: Doctorate/PhD, University of Edinburgh, UK.
1979: BSc (First Class Honours) in Microbiology, Heriot-Watt
University, Edinburgh, UK.